Ciulla TA - Search Results

1

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.

Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, Dreyer RF, Gentile RC, Sy JP, Hantsbarger G, Shams N. Heier JS, et al. Among authors: ciulla ta. Ophthalmology. 2006 Apr;113(4):633.e1-4. doi: 10.1016/j.ophtha.2005.10.052. Epub 2006 Feb 14. Ophthalmology. 2006. PMID: 16483659 Clinical Trial.

2

Evolution of a full-thickness macular hole.

Krzystolik MG, Ciulla TA, Frederick AR Jr. Krzystolik MG, et al. Among authors: ciulla ta. Am J Ophthalmol. 1998 Feb;125(2):245-7. doi: 10.1016/s0002-9394(99)80098-1. Am J Ophthalmol. 1998. PMID: 9467453

3

Age-related macular degeneration: a review of experimental treatments.

Ciulla TA, Danis RP, Harris A. Ciulla TA, et al. Surv Ophthalmol. 1998 Sep-Oct;43(2):134-46. doi: 10.1016/s0039-6257(98)00014-9. Surv Ophthalmol. 1998. PMID: 9763138 Review.

4

Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial.

Ciulla TA, Danis RP, Klein SB, Malinovsky VE, Soni PS, Pratt LM, Pugh NO, Morphis JG, Bloch C, Cameron J. Ciulla TA, et al. Am J Ophthalmol. 2002 Dec;134(6):905-6. doi: 10.1016/s0002-9394(02)01821-4. Am J Ophthalmol. 2002. PMID: 12470761 Clinical Trial.

5

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY; FOCUS Study Group. Heier JS, et al. Among authors: ciulla ta. Arch Ophthalmol. 2006 Nov;124(11):1532-42. doi: 10.1001/archopht.124.11.1532. Arch Ophthalmol. 2006. PMID: 17101999 Clinical Trial.

6

Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.

Browning DJ, Glassman AR, Aiello LP, Bressler NM, Bressler SB, Danis RP, Davis MD, Ferris FL, Huang SS, Kaiser PK, Kollman C, Sadda S, Scott IU, Qin H; Diabetic Retinopathy Clinical Research Network. Browning DJ, et al. Ophthalmology. 2008 Aug;115(8):1366-71, 1371.e1. doi: 10.1016/j.ophtha.2007.12.004. Ophthalmology. 2008. PMID: 18675696 Free PMC article.

7

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.

Ciulla TA, Rosenfeld PJ. Ciulla TA, et al. Curr Opin Ophthalmol. 2009 May;20(3):166-74. doi: 10.1097/ICU.0b013e328329d173. Curr Opin Ophthalmol. 2009. PMID: 19381089 Review.

8

Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

Ciulla TA, Rosenfeld PJ. Ciulla TA, et al. Curr Opin Ophthalmol. 2009 May;20(3):158-65. doi: 10.1097/ICU.0b013e32832d25b3. Curr Opin Ophthalmol. 2009. PMID: 19417570 Review.

9

SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.

Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA, Antoszyk AN; SCORE Study Investigator Group. Scott IU, et al. Am J Ophthalmol. 2009 Nov;148(5):725-732.e7. doi: 10.1016/j.ajo.2009.06.004. Epub 2009 Aug 11. Am J Ophthalmol. 2009. PMID: 19674727 Free PMC article. Clinical Trial.

10

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

Nguyen QD, Shah SM, Heier JS, Do DV, Lim J, Boyer D, Abraham P, Campochiaro PA; READ-2 Study Group. Nguyen QD, et al. Ophthalmology. 2009 Nov;116(11):2175-81.e1. doi: 10.1016/j.ophtha.2009.04.023. Epub 2009 Aug 22. Ophthalmology. 2009. PMID: 19700194 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters